Status:
UNKNOWN
Lung Cancer Patients' Attitudes to a Second Course of Radiotherapy
Lead Sponsor:
NHS Greater Glasgow and Clyde
Collaborating Sponsors:
University of Glasgow
The Beatson Cancer Charity
Conditions:
Lung Cancer
Recurrence
Eligibility:
All Genders
18+ years
Brief Summary
Patients with lung cancer are often treated with high dose x-ray treatment (radical radiotherapy) to control the disease. After one course of radiotherapy, after a period of time, there is a risk that...
Eligibility Criteria
Inclusion
- Age 18 years old or above
- Pathological or radiological diagnosis of non-small cell lung cancer
- Undergoing radical radiotherapy to the thorax using the following fractionations (55 Gray in 20 fractions, 54 Gray in 36 fractions or any Stereotactic Ablative Body Radiotherapy (SABR) fractionation that delivers a biological effective dose of greater than 100Gy10) as part of their primary lung cancer treatment at time of study enrolment
- Patients receiving concurrent and/or adjuvant systemic therapies are permitted
- Radiotherapy is delivered in the Beatson West of Scotland Cancer Centre
- Signed, written informed consent
- Willing and able to complete study processes
Exclusion
- Not fluent in English
Key Trial Info
Start Date :
April 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04813068
Start Date
April 16 2021
End Date
June 1 2022
Last Update
May 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Beatson West of Scotland Cancer Centre
Glasgow, United Kingdom, G12 0YN